Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
11/12/1998 | CA2289742A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
11/12/1998 | CA2289125A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase |
11/12/1998 | CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
11/12/1998 | CA2289116A1 Enterococcus faecalis polynucleotides and polypeptides |
11/12/1998 | CA2289110A1 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis |
11/12/1998 | CA2289025A1 Human serine protease precursor |
11/12/1998 | CA2288944A1 Enterococcus faecalis polynucleotides and polypeptides |
11/12/1998 | CA2288602A1 Use of a secretion vector for fertility control by oral vaccination |
11/12/1998 | CA2288374A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
11/12/1998 | CA2288232A1 Immunotoxins directed against malignant cells |
11/12/1998 | CA2288129A1 Use of virus-like particles as adjuvants |
11/12/1998 | CA2288017A1 Methods for eosinophil depletion and compositions therefor |
11/11/1998 | EP0877086A2 Recombinant YF virus vaccines recovered from the infectious cDNA |
11/11/1998 | EP0877085A1 OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/11/1998 | EP0877083A1 A novel human G-protein coupled receptor (HCEPT09) |
11/11/1998 | EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
11/11/1998 | EP0877030A2 EPO primary response gene 1,(EPRG1) |
11/11/1998 | EP0876614A1 Method of predicting resistance to hepatitis c infection |
11/11/1998 | EP0876613A1 Treatment and diagnosis of infections due to helicobacter pylori |
11/11/1998 | EP0876612A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
11/11/1998 | EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv |
11/11/1998 | EP0876487A1 Mammalian cx 3?c chemokine genes |
11/11/1998 | EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
11/11/1998 | EP0876485A2 NOVEL CREBa ISOFORM |
11/11/1998 | EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
11/11/1998 | EP0876482A1 Il-13 receptor polypeptide |
11/11/1998 | EP0876476A1 Heterophil-adapted poultry vaccine |
11/11/1998 | EP0876398A1 Induction of immune response against desired determinants |
11/11/1998 | EP0876397A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
11/11/1998 | EP0876157A1 Methods and compositions for passive immunotherapy |
11/11/1998 | EP0876156A1 Compositions and methods for administering borrelia burgdorferi antigens |
11/11/1998 | EP0876153A2 Medical use of proteases |
11/11/1998 | EP0876150A1 Non-toxic mutants of pathogenic gram-negative bacteria |
11/11/1998 | EP0744940B1 Drugs, vaccines and hormones in polylactide coated microspheres |
11/11/1998 | EP0701604B1 Immortalization of denditric cells with v-myc oncogene |
11/11/1998 | EP0659086B1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
11/11/1998 | CN1198674A Vaccines |
11/10/1998 | US5834594 Polyethylene-protein conjugates |
11/10/1998 | US5834592 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
11/10/1998 | US5834591 Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin |
11/10/1998 | US5834587 G-protein coupled receptor, HLTEX 11 |
11/10/1998 | US5834429 Inhibiting binding of a hiv antigen to receptors on cells of mammals |
11/10/1998 | US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors |
11/10/1998 | US5834307 Recombinant polynucleotide which codes for a polypeptide from a cytomegalovirus glycoprotein; for vaccines, diagnosis |
11/10/1998 | US5834302 Method for producing RNA viruses from CDNA |
11/10/1998 | US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus |
11/10/1998 | US5834267 Pure hiv antigen |
11/10/1998 | US5834238 Human GTP binding protein |
11/10/1998 | US5834220 Incubation/complexing with antibodies specific to the cardiac form, forming a ternary complex with troponin c, improved diagnosis of heart attacks |
11/10/1998 | US5834210 Stable troponin subunits and complexes |
11/10/1998 | US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment |
11/10/1998 | US5834187 Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable Haemophilus influenzae |
11/10/1998 | US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same |
11/10/1998 | US5834001 Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core |
11/10/1998 | US5833996 Treatment of psoriasis using dead cells of Mycobacterium vaccae |
11/10/1998 | US5833995 Innoculating with a polypeptide comprising an anigenic portion of the virus stuctural protein |
11/10/1998 | US5833993 Feline immunodeficiency virus vaccine |
11/10/1998 | US5833991 A glycine-rich amino acid sequence is inserted into a fusion protein to prevent an immunogenic response; gene therapy; transfer vectors; vaccines |
11/10/1998 | US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides |
11/10/1998 | US5833987 Treatment of T cell mediated autoimmune disorders |
11/10/1998 | US5833986 Methods of inhibiting the growth of neoplasia using a monoclonal antibody against α platelet derived growth factor receptor |
11/10/1998 | US5833985 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity |
11/10/1998 | US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A |
11/10/1998 | US5833983 Interleukin 2 receptor and applications thereof |
11/10/1998 | US5833980 Inoculating poultry, live virus vaccine |
11/10/1998 | US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
11/10/1998 | US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
11/10/1998 | CA2045649C Attenuated enteroviruses and rhinoviruses |
11/07/1998 | CA2231754A1 A novel human g-protein coupled receptor hcept09 |
11/07/1998 | CA2230986A1 Epo primary response gene 1, eprg1 |
11/05/1998 | WO1998049561A1 Inhibitors of nuclear protein/nuclear receptor interaction |
11/05/1998 | WO1998049333A2 Eukaryotic gene expression cassette and uses thereof |
11/05/1998 | WO1998049314A2 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
11/05/1998 | WO1998049313A2 Characterization of granulocytic ehrlichia and methods of use |
11/05/1998 | WO1998049312A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia |
11/05/1998 | WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
11/05/1998 | WO1998049296A1 Human cerberus protein |
11/05/1998 | WO1998049294A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
11/05/1998 | WO1998049292A2 Polypeptides associated with activator receptors and their biological applications |
11/05/1998 | WO1998049285A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
11/05/1998 | WO1998049270A1 Cytolytic t-cell clones against colorectal carcinoma and methods of use thereof |
11/05/1998 | WO1998049198A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
11/05/1998 | WO1998049195A1 Corona virus-like particles as tools for vaccination and therapy |
11/05/1998 | WO1998049192A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
11/05/1998 | WO1998049135A1 Compounds and compositions for delivering active agents |
11/05/1998 | WO1998048837A1 Polyalkylene oxide-modified single chain polypeptides |
11/05/1998 | WO1998048836A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant |
11/05/1998 | WO1998048835A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method |
11/05/1998 | WO1998048832A1 Nerve growth factor as a vaccine adjuvant |
11/05/1998 | WO1998048780A1 Vesicular complexes and methods of making and using the same |
11/05/1998 | WO1998048626A1 Methods and compositions for administering dna to mucosal surfaces |
11/05/1998 | WO1998039450A3 Surface protein (spsa protein) of streptococcus pneumoniae, deleted derivatives, expression system for said proteins and vaccine system with said proteins |
11/05/1998 | WO1998039025A3 A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
11/05/1998 | WO1998034954A3 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof |
11/05/1998 | WO1998033527A3 Cancer immunotherapy with semi-allogeneic cells |
11/05/1998 | WO1998031786A3 Novel microorganisms |
11/05/1998 | WO1998030593A3 Assay of histidine decarboxylase to detect cancer |
11/05/1998 | DE19712541C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
11/05/1998 | CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/05/1998 | CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |